Quick take: This morning’s strongest developments are less about spectacular inventions than about whether systems reveal what matters: a pregnancy-memory mechanism, a dissolving medical power source, resource labels, cyber incident sharing and pharmacy-market data.
Pregnancy-memory study finds a possible circuit, not a diagnosis
A study published on 25 August and reported more widely on 21 September offers a biological lead on “pregnancy brain” without proving a simple human cause. In mice, sustained high estrogen increased activity in a hypothalamus-to-hippocampus pathway; suppressing that pathway or removing estrogen receptors there prevented temporary memory problems. In 70 women, the researchers found task-specific impairment late in pregnancy associated with higher estrogen, but the human evidence was correlational and did not establish that the same circuit caused it. The promise is a more precise explanation for a common experience that is often dismissed. The danger is turning an early mechanism into a stereotype about pregnant people’s competence—or a treatment claim before clinical trials. For individuals and employers, the useful response is practical: use reminders, reduce avoidable cognitive load and treat severe or persistent symptoms as a reason for clinical assessment, not as inevitable “momnesia.” Source: study abstract and publication record.
Possible Alkemata article: Pregnancy Brain Without the Stereotype
A battery designed to disappear powers ingestible devices in pigs
On 21 September, researchers reported a magnesium–molybdenum-trioxide paper battery that reached 1.84 volts and powered capsule-scale electronics inside pigs. The system supported wireless medication tracking and gastric electrical stimulation; wax encapsulation delayed degradation, and one test retained useful function in the stomach for three days. This is promising because conventional button and lithium batteries can leak, injure tissue or require retrieval, while a bioresorbable power source could reduce both risk and electronic waste. But this remains an animal study, not a human-ready product. The battery dissolved, while some accompanying electronics still had to pass through the body, and safety will depend on the complete device rather than one component. A patient offered an ingestible electronic in future should ask what parts dissolve, what evidence exists in humans, how retention is detected and what the recovery plan is if the capsule does not pass. Source: Nature Chemical Engineering paper, published 21 September.
Possible Alkemata article: When Medical Electronics Are Designed to Disappear
Europe moves data-centre transparency from scattered figures to a common label
What is materially new: after earlier national debates about data-centre power costs and permits, the European Commission put forward an EU-wide efficiency package on 21 September. Operators above 500 kilowatts will receive an electronic sustainability label based on reported indicators including energy and water efficiency, clean-energy use and waste-heat reuse; a consultation on minimum performance standards also begins. Comparable data can help communities, grid planners and customers challenge vague “green” claims. The limitation is equally important: a good efficiency ratio can coexist with rapidly rising total electricity and water demand, and the label is disclosure—not yet a hard resource cap. With European data-centre capacity expected to more than double by 2030, local consequences will depend on absolute consumption, water stress and who pays for grid expansion. Residents and public buyers should read the label alongside total megawatt-hours, litres consumed in dry periods and enforceable connection conditions. Source: Reuters, 21 September; European Commission policy context.
Possible Alkemata article: Efficiency Labels Need Absolute Resource Numbers
An EU audit finds the cyber-warning machinery is still not being used
What is materially new: last week’s review covered Europe’s reporting duties moving into operation; a European Court of Auditors assessment released on 21 September now documents an implementation failure. Despite cross-border attacks, no member state has classified an incident as “large-scale” since the EU’s coordination arrangements began in 2016. The auditors highlighted the September 2025 ransomware disruption at airports in several countries, yet affected states did not activate the relevant EU information-sharing channels. Shared, timely evidence could help other operators contain the same attack and let citizens receive coherent guidance. The danger is a paper architecture in which national-security sensitivities, inconsistent thresholds and fear of reputational damage suppress useful warnings. For travellers and organisations, the immediate action is mundane but real: keep an offline continuity plan and ask service providers who must notify whom, by what deadline and through which fallback channel when shared infrastructure fails. Source: Reuters on the ECA audit, 21 September.
Possible Alkemata article: A Warning Is Only Real When Someone Can Act
Poland’s pharmacy loyalty data became a tool for policing a cartel
Poland’s competition authority said on 21 September that four pharmaceutical wholesalers had shared pricing information for more than a decade and imposed total fines of nearly 905 million zlotys. Neuca received 499 million zlotys of that amount. According to the authority, purchasing data gathered through pharmacy loyalty programmes let wholesalers see rivals’ prices and terms for individual pharmacies, then adjust their own offers. The promising part is enforcement supported by a leniency programme: one participant supplied evidence and escaped a fine. The deeper warning is that data collected for “loyalty” can become surveillance infrastructure for suppliers in a market where the three largest groups control more than 70 percent of wholesale trade. The decision is not final and may be appealed, so the authority’s findings and the final legal outcome must remain distinct. Pharmacy customers can ask what their loyalty account records, who receives the data and whether discounts justify identifiable purchase histories. Source: Poland’s Office of Competition and Consumer Protection, 21 September.
Possible Alkemata article: When Loyalty Data Becomes Market Surveillance
